Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ann-Kathrin Stoppek"'
Autor:
Ann-Kathrin Stoppek, Sied Kebir, Andreas Junker, Kathy Keyvani, Stefan Zülow, Lazaros Lazaridis, Teresa Schmidt, Daniela Pierscianek, Martin Stuschke, Ulrich Sure, Christoph Kleinschnitz, Björn Scheffler, Lisa Zimmer, Martin Glas
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-4 (2019)
Abstract Background Leptomeningeal metastasis (LM) is a predominantly late stage, devastating complication of a variety of malignant solid tumors. Diagnosis relies predominantly on neurological, radiographic, and cerebrospinal fluid (CSF) assessments
Externí odkaz:
https://doaj.org/article/ca01be0693834cb09b9d301077a5a5b9
Autor:
Sied Kebir, Patrick M. Colletti, Gerald Antoch, Tobias Blau, Kathy Keyvani, Björn Scheffler, Domenico Rubello, Ann-Kathrin Stoppek, Martin Stuschke, Christoph Mönninghoff, Christoph Kleinschnitz, Lale Umutlu, Ulrich Sure, Martin Glas, Cornelius Deuschl, Michael Forsting, Daniela Pierscianek, Ken Herrmann, Manuel Weber, Teresa Schmidt, Lazaros Lazaridis
Publikováno v:
Clinical nuclear medicine. 44(6)
AIMS Amino acid PET and magnetic resonance spectroscopy (MRS) are at the forefront of noninvasive imaging techniques used for detection and subtyping of glioma-suspicious lesions. In this pilot study, we compare L-methyl-C-methionine PET and MRS for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aea302f497dd5fa2b67ef0f1a4abfc86
https://pubmed.ncbi.nlm.nih.gov/30985412
https://pubmed.ncbi.nlm.nih.gov/30985412
Autor:
Teresa Schmidt, Christoph Kleinschnitz, Daniela Pierscianek, Lazaros Lazaridis, Kathy Keyvani, Björn Scheffler, Ulrich Sure, Martin Glas, Alexander Radbruch, Laurèl Rauschenbach, Martin Stuschke, Ann-Kathrin Stoppek, Michael Forsting, Sied Kebir
Antiangiogenic treatment approaches have failed to improve outcome in randomized trials of high-grade astrocytoma. One key mechanism of resistance to antiangiogenic treatment may concern the upregulation of alternative pro-angiogenic pathways. Regora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb534b8a76881625a9663f09ddec29d1
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85062634465
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85062634465
Autor:
Ulrich Sure, Martin Glas, Sied Kebir, Daniela Pierscianek, Kathy Keyvani, Ken Herrmann, Teresa Schmidt, Manuel Weber, Cornelius Deuschl, Christoph Moenninghoff, Christoph Kleinschnitz, Lazaros Lazaridis, Ann-Kathrin Stoppek, Björn Scheffler, Judith Boehm
BACKGROUND: Amino acid positron emission tomography (PET) and magnetic resonance spectroscopy (MRS) are at the forefront of non-invasive imaging techniques used for detection and subtyping of glioma-suspicious lesions. No reported studies so far atte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6651a121b8063cf6d63c8543c04247
Publikováno v:
Neuro Oncol
BACKGROUND Tumor Treating Fields (TTFields) are established as modality in glioblastoma (GBM) therapy. GBM is the most aggressive brain tumor in adults, constituting approximately 15 % of all primary brain tumors. At diagnosis, a considerable subgrou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcac34c0bc7f353381275b7764f46750
https://doi.org/10.1093/neuonc/noz126.297
https://doi.org/10.1093/neuonc/noz126.297
Autor:
Christoph Kleinschnitz, Teresa Schmidt, Ann-Kathrin Stoppek, Daniela Pierscianek, Björn Scheffler, Ulrich Herrlinger, Ulrich Sure, Martin Glas, Lazaros Lazaridis, Sied Kebir, Johannes Weller, Martin Stuschke, Theophilos-Dimitrios Tzaridis, Niklas Schäfer
Publikováno v:
Neuro Oncol
BACKGROUND TTFields combined with TMZ demonstrated significantly improved PFS, OS and long-term survival in newly diagnosed glioblastoma (ndGBM) patients, compared to TMZ monotherapy in the EF-14 trial; independent of MGMT-promotor methylation-status
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfa41a2cada089530ec1a043127a5958
https://doi.org/10.1093/neuonc/noz126.296
https://doi.org/10.1093/neuonc/noz126.296
Publikováno v:
Cancer Research. 79:CT187-CT187
Objective: We aimed to identify and compare glioblastoma (GBM) Phase III trials of the years 2005 to 2018. Methods:A systematic literature search using PubMed and ClinicalTrials.gov was conducted to provide an overview of clinically relevant GBM Phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c6fb3051318ab4d2bb06c4e2c6e8a5e
https://doi.org/10.1158/1538-7445.am2019-ct187
https://doi.org/10.1158/1538-7445.am2019-ct187